BioSpace News Archive

HistoSonics® announced that the company’s Edison System has been selected to participate in the UK’s newly created Innovative Devices Access Pathway Pilot Program designed to accelerate the development of cost-effective medical devices and their integration into the UK market.

Genmab A/S announced the publication of its Annual Report for 2023.

Medline announced it has expanded its prime vendor agreement with California-based healthcare network PIH Health.

Genmab A/S announced that it is initiating a share buy-back program to honor our commitments under our Restricted Stock Unit program.

Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced Regional Medical Oncology Center (RMOC) in Wilson, NC as the second site activated in the STAR-LLD Phase 1b clinical trial.

The American Academy of Orthopaedic Surgeons named CytexOrtho the winner of the inaugural OrthoPitch Technology Competition during the AAOS 2024 Annual Meeting in San Francisco.

Tevogen Bio Holdings Inc. has announced the completion of Tevogen Bio Inc’s previously announced business combination with Semper Paratus Acquisition Corporation, leading to the formation of Tevogen Bio Holdings Inc.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and full year 2023 after the market close on Wednesday, February 28, 2024.

Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) today announced the launch of the Ergo-Series of the OMNI® Surgical System in Europe, a technology that facilitates surgeons’ ability to perform minimally invasive, implant-free glaucoma procedures in adults with open-angle glaucoma.

Dyne Therapeutics, Inc. announced two oral presentations at the Muscular Dystrophy Association Clinical & Scientific Conference being held March 3-6, 2024, in Orlando, Florida and virtually.